1. Home
  2. IVA vs IMXI Comparison

IVA vs IMXI Comparison

Compare IVA & IMXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • IMXI
  • Stock Information
  • Founded
  • IVA 2011
  • IMXI 1994
  • Country
  • IVA France
  • IMXI United States
  • Employees
  • IVA N/A
  • IMXI N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • IMXI Retail: Computer Software & Peripheral Equipment
  • Sector
  • IVA Health Care
  • IMXI Technology
  • Exchange
  • IVA Nasdaq
  • IMXI Nasdaq
  • Market Cap
  • IVA 359.6M
  • IMXI 302.5M
  • IPO Year
  • IVA 2020
  • IMXI N/A
  • Fundamental
  • Price
  • IVA $3.01
  • IMXI $10.83
  • Analyst Decision
  • IVA Strong Buy
  • IMXI Buy
  • Analyst Count
  • IVA 4
  • IMXI 7
  • Target Price
  • IVA $10.50
  • IMXI $19.60
  • AVG Volume (30 Days)
  • IVA 18.3K
  • IMXI 347.2K
  • Earning Date
  • IVA 03-26-2025
  • IMXI 08-06-2025
  • Dividend Yield
  • IVA N/A
  • IMXI N/A
  • EPS Growth
  • IVA N/A
  • IMXI 1.60
  • EPS
  • IVA N/A
  • IMXI 1.70
  • Revenue
  • IVA $14,591,573.00
  • IMXI $652,547,000.00
  • Revenue This Year
  • IVA $15.38
  • IMXI N/A
  • Revenue Next Year
  • IVA $24.22
  • IMXI $3.03
  • P/E Ratio
  • IVA N/A
  • IMXI $6.36
  • Revenue Growth
  • IVA N/A
  • IMXI N/A
  • 52 Week Low
  • IVA $1.53
  • IMXI $9.76
  • 52 Week High
  • IVA $4.05
  • IMXI $22.38
  • Technical
  • Relative Strength Index (RSI)
  • IVA 40.84
  • IMXI 53.06
  • Support Level
  • IVA $3.00
  • IMXI $9.76
  • Resistance Level
  • IVA $3.23
  • IMXI $10.49
  • Average True Range (ATR)
  • IVA 0.21
  • IMXI 0.36
  • MACD
  • IVA -0.04
  • IMXI 0.10
  • Stochastic Oscillator
  • IVA 5.08
  • IMXI 92.64

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

Share on Social Networks: